Different approaches to inhibit the chymotrypsin-like activity of the 20S proteasome

被引：0
|
作者：
Furet, Pascal [1 ]
Imbach, Patricia [1 ]
Garcia-Echeverria, Carlos [1 ]
Lang, Marc [1 ]
Roesel, Johannes [1 ]
Noorani, Maria [1 ]
Zimmermann, Johann [1 ]
Fuerst, Peter [1 ]
Guagnano, Vito [1 ]
机构：
[1] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland
来源：
PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS | 2004年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：307 / 309
页数：3
相关论文
共 50 条
  • [1] Different approaches to inhibit the chymotrypsin like activity of the 20S proteasome
    Furet, P
    Guagnano, V
    Imbach, P
    Lang, M
    Roesel, J
    Noorani, M
    Zimmermann, J
    Fuerst, P
    García-Echeverría, C
    BIOPOLYMERS, 2003, 71 (03) : 395 - 395
  • [2] α- and β-hydrazino acid-based pseudopeptides inhibit the chymotrypsin-like activity of the eukaryotic 20S proteasome
    Bordessa, Andrea
    Keita, Massaba
    Marechal, Xavier
    Formicola, Lucia
    Lagarde, Nathalie
    Rodrigo, Jordi
    Bernadat, Guillaume
    Bauvais, Cyril
    Soulier, Jean-Louis
    Dufau, Laure
    Milcent, Thierry
    Crousse, Benoit
    Reboud-Ravaux, Michele
    Ongeri, Sandrine
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 70 : 505 - 524
  • [3] Elastase-like Activity Is Dominant to Chymotrypsin-like Activity in 20S Proteasome's β5 Catalytic Subunit
    Bensinger, Dennis
    Neumann, Theresa
    Scholz, Christoph
    Voss, Constantin
    Knorr, Sabine
    Kuckelkorn, Ulrike
    Hamacher, Kay
    Kloetzel, Peter-Michael
    Schmidt, Boris
    ACS CHEMICAL BIOLOGY, 2016, 11 (07) : 1800 - 1804
  • [4] Proteasome 20S in multiple myeloma: comparison of concentration and chymotrypsin-like activity in plasma and serum
    Romaniuk, Wioletta
    Kalita, Joanna
    Ostrowska, Halina
    Kloczko, Janusz
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2018, 78 (04): : 253 - 257
  • [5] Novel β-lactam derivatives:: Potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome
    Imbach, Patricia
    Lang, Marc
    Garcia-Echeverria, Carlos
    Guagnano, Vito
    Noorani, Maria
    Roesel, Johannes
    Bitsch, Francis
    Rihs, Grety
    Furet, Pascal
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (02) : 358 - 362
  • [6] Design and synthesis of 2-aminobenzylstatine-based inhibitors of the chymotrypsin-like activity of the 20S proteasome.
    Garcia-Echeverria, C
    Imbach, P
    Roesel, J
    Fürst, P
    Lang, M
    Guagnano, V
    Noorani, M
    Zimmermann, J
    Furet, P
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3727S - 3727S
  • [7] A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasome
    Garcia-Echeverría, C
    Imbach, P
    France, D
    Fürst, P
    Lang, M
    Noorani, M
    Scholz, D
    Zimmermann, J
    Furet, P
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (10) : 1317 - 1319
  • [8] Selective inhibition of the chymotrypsin-like activity of the 20S proteasome by 5-methoxy-1-indanone dipeptide benzamides
    Lum, RT
    Nelson, MG
    Joly, A
    Horsma, AG
    Lee, G
    Meyer, SM
    Wick, MM
    Schow, SR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (03) : 209 - 214
  • [9] Human platelet 20S proteasome: inhibition of its chymotrypsin-like activity and identification of the proteasome activator PA28. A preliminary report
    Ostrowska, H
    Ostrowska, JK
    Worowski, K
    Radziwon, P
    PLATELETS, 2003, 14 (03) : 151 - 157
  • [10] 19F NMR monitoring of the eukaryotic 20S proteasome chymotrypsin-like activity: an investigative tool for studying allosteric regulation
    Keita, M.
    Kaffy, J.
    Troufflard, C.
    Morvan, E.
    Crousse, B.
    Ongeri, S.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2014, 12 (26) : 4576 - 4581
12345